Covid19
4 competing products in clinical development for Covid19.
Pipeline by Phase
Phase 11
Phase 22
Approved1
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Icosapent ethyl | Amarin Corporation | Approved | Terminated | 77 |
| Favipiravir + Nitazoxanide | Strides Pharma | Phase 2 | Completed | 51 |
| GX-03 + Petrolatum ointment | Turn Therapeutics | Phase 2 | Completed | 44 |
| Cytotoxic T Lymphocytes | Tevogen Bio | Phase 1 | Completed | 25 |